已收录 267400 条政策
 政策提纲
  • 暂无提纲
Natural Products for Metabolic Syndrome
[摘要] BackgroundMetabolic syndrome (MetS) is a multifactorial disorder characterized by central obesity, insulin resistance, dyslipidemia, hypertension, and chronic low-grade inflammation, collectively increasing the risk of cardiovascular disease and type 2 diabetes. Current therapeutic approaches are often limited by their single-target mechanisms, adverse effects, and economic burden. Natural products have emerged as promising therapeutic candidates because of their ability to modulate multiple interconnected pathological pathways involved in MetS.Key FindingsThis editorial highlights recent advances in the discovery and mechanistic evaluation of natural products for the prevention and management of MetS. Evidence from the studies included in this collection demonstrates that diverse bioactive natural compounds can regulate glucose and lipid metabolism, attenuate inflammation and oxidative stress, improve mitochondrial function, and restore metabolic homeostasis. These findings support the concept that natural products may address the complex and interconnected pathophysiology of MetS more effectively than single-target interventions.ConclusionsNatural products represent a valuable foundation for integrative, systems-based strategies aimed at managing MetS and its associated metabolic complications. However, further efforts are required to overcome challenges related to bioavailability, pharmacokinetic properties, standardization, and clinical translation before their full therapeutic potential can be realized. Continued multidisciplinary research will be essential to advance natural product-based interventions from preclinical discovery to clinical application.
[发布日期] 2026-08-01 [发布机构] 
[效力级别]  [学科分类] 
[关键词] metabolic syndrome;biological products;nutraceuticals;insulin resistance;inflammation;oxidative stress [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文